Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cardiovascular Diseases 3Breast Neoplasms 3Metabolic Syndrome 2Sarcoidosis 1Rectal Neoplasms 1Obesity 1Non-alcoholic Fatty Liver Disease 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases, Interstitial 1Liver Cirrhosis 1Hodgkin Disease 1Fatigue 1Colorectal Neoplasms 1Cardiotoxicity 1Breast Diseases 1

Interventions

Exercise 35Therapeutics 30Modafinil 21Yoga 17Surveys and Questionnaires 16Methylphenidate 16Psychiatric Rehabilitation 14Acupuncture Therapy 11Educational Status 9Walking 8Early Intervention, Educational 8Cognitive Behavioral Therapy 8Ultraviolet Therapy 7Control Groups 7Therapeutic Touch 6Physical Therapy Modalities 6Mental Status and Dementia Tests 6Exercise Therapy 6Acceptance and Commitment Therapy 6Sugars 5Qigong 5Palliative Care 5Counseling 5Standard of Care 4Saline Solution 4Methods 4Epoetin Alfa 4Dexamethasone 4Behavior Therapy 4Acupressure 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Blood Pressure × Clear all
NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Clinical Research Support Center Kyush

Phase 2 Unknown
74 enrolled
Gastrointestinal

Fatigue, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡